NCT02219633View on ClinicalTrials.gov

Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions

Atopic Dermatitis

Interventions

DRUG

LEO 39652 cream

Applied for 21 days

Trial Locations (1)

48159

proinnovera GmbH, Center of Dermatology Excellence, Münster

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY